Accendra Health (ACH) Capital Expenditures (2009 - 2026)

Accendra Health (ACH) has reported Capital Expenditures for 18 consecutive years, with $17.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 22.82% year-over-year to $17.2 million in Q2 2026; TTM through Jun 2026 was $176.8 million, a 3.57% decrease from a year earlier, with the FY2025 full-year figure at $191.0 million, up 12.14% from the prior year.
• Capital Expenditures was $17.2 million for Q2 2026 at Accendra Health, down from $72.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $87.0 million in Q2 2024 and troughed at $3.4 million in Q1 2024.
• A 5-year average of $43.4 million and a median of $46.8 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures plunged 92.61% in 2024 and surged 2277.16% in 2025, its largest moves.
• Over 5 years, Capital Expenditures stood at $48.8 million in 2022, then plunged by 34.66% to $31.9 million in 2023, then plunged by 30.23% to $22.3 million in 2024, then slumped by 40.99% to $13.1 million in 2025, then jumped by 31.23% to $17.2 million in 2026.
• The last three Capital Expenditures figures came in at $17.2 million (Q2 2026), $72.0 million (Q1 2026), and $13.1 million (Q4 2025), per Business Quant data.